Remifentanil; from pharmacological properties to clinical practice

Advances in Experimental Medicine and Biology

Volumn 523, Issue , 2003, Pages 245-260

  Servin, Frederique ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 METHOXYCARBONYL 4 (N PHENYLPROPIONAMIDO)PIPERIDINO]PROPIONIC ACID; ALFENTANIL; DRUG METABOLITE; FENTANYL; GI 94219; KETAMINE; MORPHINE; PARACETAMOL; PROPOFOL; REMIFENTANIL; UNCLASSIFIED DRUG;

ANALGESIA; ANESTHESIA MECHANISM; BOLUS INJECTION; BRAIN BLOOD FLOW; CONFERENCE PAPER; CONTINUOUS INFUSION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENCY; DRUG TOLERANCE; ENDOTRACHEAL INTUBATION; HEMODYNAMICS; HUMAN; INTRAVENOUS ANESTHESIA; NEUROSURGERY; OPEN HEART SURGERY; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SIDE EFFECT;

EID: 0037254625     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9192-8_22     Document Type: Conference Paper

References (135)

1. T.D. Egan, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL, The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 79, 881-92 (1993).
2. T.D. Egan, Minto CF, Hermann DJ, Barr J, Muir KT, Shafer SL: Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 84, 821-33 (1996).
3. P.S. Glass, Iselin-Chaves IA, Goodman D, Delong E, Hermann DJ: Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect. Anesthesiology 90, 1556-63 (1999).
4. A. Kapila, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL: Measured context-sensitive half-times of remifentanil and alfentanil [see comments]. Anesthesiology 83, 968-75 (1995).
5. T.D. Egan, Remifentanil pharmacokinetics and pharmacodynamics. A preliminary appraisal. Clin Pharmacokinet 29, 80-94 (1995).
6. H. Burkle, Dunbar S, Van Aken H, Remifentanil: a novel, short-acting, mu-opioid, Anesth Analg, 83: 646-51 (1996).
7. J. Manullang, Egan TD, Remifentanil's effect is not prolonged in a patient with pseudocholinesterase deficiency, Anesth Analg; 89, 529-30 (1999).
8. H. Buerkle, Yaksh TL, Continuous intrathecal administration of shortlasting mu opioids remifentanil and alfentanil in the rat, Anesthesiology, 84: 926-35 (1996).
9. S.L. Shafer, Varvel JR, Pharmacokinetics, pharmacodynamics, and rational opioid selection, Anesthesiology, 74: 53-63 (1991).
10. M. Hughes, Glass P, Jacobs R, Context-sensitive half time in multicompartment pharmacokinetic models for intravenous anesthetic drugs, Anesthesiology, 76: 334-341 (1992).
11. E.J. Youngs, Shafer SL, Pharmacokinetic parameters relevant to recovery from opioids. Anesthesiology, 81: 833-42 (1994).
12. C.L. Westmoreland, Hoke JF, Sebel PS, Hug CC, Jr., Muir KT, Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Anesthesiology, 79: 893-903 (1993).
13. C.F. Minto, Schnider TW, Egan TD, Young E, Lermnens HJM, Gambus PL, Billard V, Hoke JF, Moore KHP, Hermann DJ, Muir KT, Mandema JW, Shafer SL, Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development, Anesthesiology, 86: 10-23 (1997).
14. M. Dershwitz, Hoke JF, Rosow CE, Michalowski P, Connors PM, Muir KT, Dienstag JL, Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease Anesthesiology, 84: 812-20 (1996).
15. V.U. Navapurkar, Archer S, Gupta SK, Muir KT, Frazer N, Park GR, Metabolism of remifentanil during liver transplantation, Br J Anaesth, 81: 881-6 (1998).
16. J.F. Hoke, Shlugman D, Dershwitz M, Michalowski P, Malthouse-Dufore S, Connors PM, Martel D, Rosow CE, Muir KT, Rubin N, Glass PS, Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers, Anesthesiology, 87: 533-41 (1997).
17. T.D. Egan, Huizinga B, Gupta SK, Jaarsma RL, Sperry RJ, Yee JB, Muir KT, Remifentanil pharmacokinetics in obese versus lean patients, Anesthesiology, 89: 562-73 (1998).
18. R.E. Kan, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP, Intravenous remifentanil: placental transfer, maternal and neonatal effects, Anesthesiology, 88: 1467-74 (1998).
19. A.K. Ross, Davis PJ, Dear Gd GL, Ginsberg B, McGowan FX, Stiller RD, Henson LG, Huffman C, Muir KT, Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures, Anesth Analg 93, 1393-401 (2001).
20. C.F. Minto, Schnider TW, Shafer SL, Pharmacokinetics and pharmacodynamics of remifentanil. II Model application, Anesthesiology, 86: 24-33 (1997).
21. P.S. Glass, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D, Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B), Anesth Analg, 77: 1031-40 (1993).
22. P.L. Gambus, Gregg KM, Shafer SL, Validation of the alfentanil canonical univariate parameter as a measure of opioid effect on the electroencephalogram, Anesthesiology, 83: 747-56 (1995).
23. E. Lang, Kapila A, Shlugman D, Hoke JF, Sebel PS, Glass PS, Reduction of isoflurane minimal alveolar concentration by remifentanil, Anesthesiology, 85: 721-8 (1996).
24. M.L. Black, Hill JL, Zacny JP, Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers, Anesthesiology, 90: 718-26 (1999).
25. H.M. Amin, Sopchak AM, Esposito BF, Henson LG, Batenhorst RL, Fox AW, Camporesi EM, Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil, J Pharmacol Exp Ther, 274: 34-9 (1995).
26. R. Wuesten, Van Aken H, Glass PS, Buerkle H, Assessment of depth of anesthesia and postoperative respiratory recovery after remifentanil- versus alfentanil-based total intravenous anesthesia in patients undergoing ear-nose-throat surgery, Anesthesiology, 94: 211-7 (2001).
27. H.D. Babenco, Conard PF, Gross JB, The pharmacodynamic effect of a remifentanil bolus on ventilatory control, Anesthesiology, 92: 393-8 (2000).
28. M.K. James, Vuong A, Grizzle MK, Schuster SV, Shaffer JE, Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs, J Pharmacol Exp Ther, 263: 84-91 (1992).
29. K. Shinohara, Aono H, Unruh GK, Kindscher JD, Goto H, Suppressive effects of remifentanil on hemodynamics in baro-denervated rabbits, Can J Anaesth, 47: 361-6 (2000).
30. P. Elliott, O'Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK, Severe cardiovascular depression with remifentanil, Anesth Analg, 91: 58-61 (2000).
31. J.E. Reid, Mirakhur RK, Bradycardia after administration of remifentanil, Br J Anaesth, 84: 422-3 (2000).
32. S. Mouren, De Winter G, Guerrero SP, Baillard C, Bertrand M, Coriat P, The continuous recording of blood pressure in patients undergoing carotid surgery under remifentanil versus sufentanil analgesia, Anesth Analg, 93: 1402-9, table of contents (2001).
33. J.L. Hanouz, Yvon A, Guesne G, Eustratiades C, Babatasi G, Rouet R, Ducouret P, Khayat A, Bricard H, Gerard JL, The in vitro effects of remifentanil, sufentanil, fentanyl, and alfentanil on isolated human right atria, Anesth Analg, 93: 543-9 (2001).
34. P.S. Sebel PS, Hoke JF, Westmoreland C, Hug CC, Jr., Muir KT, Szlam F, Histamine concentrations and hemodynamic responses after remifentanil, Anesth Analg, 80: 990-3 (1995).
35. W.E. Hoffman WE, Cunningham F, James MK, Baughman VL, Albrecht RF, Effects of remifentanil, a new short-acting opioid, on cerebral blood flow, brain electrical activity, and intracranial pressure in dogs anesthetized with isoflurane and nitrous oxide, Anesthesiology, 79: 107-13, 26A (1993).
36. K.J. Wagner, Willoch F, Kochs EF, Siessmeier T, Tolle TR, Schwaiger M, Bartenstein P, Dose-dependent regional cerebral blood flow changes during remifentanil infusion in humans: a positron emission tomography study, Anesthesiology, 94: 732-9 (2001).
37. N.D. Ostapkovich, Baker KZ, Fogarty-Mack P, Sisti MB, Young WL, Cerebral blood flow and CO2 reactivity is similar during remifentanil/N2O and fentanyl/N2O anesthesia, Anesthesiology, 89: 358-63 (1998).
38. I.H. Lorenz, Kolbitsch C, Hormann C, Schocke M, Zschiegner F, Felber S, Benzer A, The effects of remifentanil on cerebral capacity in awake volunteers, Anesth Analg, 90: 609-13 (2000).
39. A.A. Artru, Momota T, Rate of CSF formation and resistance to reabsorption of CSF during sevoflurane or remifentanil in rabbits, J Neurosurg Anesthesiol, 12: 37-43 (2000).
40. K.Z. Baker, Ostapkovich N, Sisti MB, Warner DS, Young WL, Intact cerebral blood flow reactivity during remifentanil/nitrous oxide anesthesia, J Neurosurg Anesthesiol, 9: 134-40 (1997).
41. H. Buerkle, Yaksh TL, Comparison of the spinal actions of the mu-opioid remifentanil with alfentanil and morphine in the rat, Anesthesiology, 84: 94-102 (1996).
42. H. Buerkle, Marsala M, Yaksh TL, Effect of continuous spinal remifentanil infusion on behaviour and spinal glutamate release evoked by subcutaneous formalin in the rat, Br J Anaesth, 80: 348-53 (1998).
43. R. Jhaveri, Joshi P, Batenhorst R, Baughman V, Glass PS, Dose comparison of remifentanil and alfentanil for loss of consciousness, Anesthesiology, 87: 253-9 (1997).
44. H. Ropcke, Konen-Bergmann M, Cuhls M, Bouillon T, Hoeft A, Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index, J Clin Anesth, 13: 198-207 (2001).
45. J.E. Peacock, Luntley JB, O'Connor B, Reilly CS, Ogg TW, Watson BJ, Shaikh S: Rernifentanil in combination with propofol for spontaneous ventilation anaesthesia, Br J Anaesth, 80: 509-11 (1998).
46. J. Vuyk J, Pharmacokinetic and pharmacodynamic interactions between opioids and propofol, J Clin Anesth 9: 23S-26S (1997).
47. C. Lysakowski, Dumont L, Pellegrini M, Clergue F, Tassonyi E, Effects of fentanyl, alfentanil, remifentanil and sufentanil on loss of consciousness and bispectral index during propofol induction of anaesthesia, Br J Anaesth, 86: 523-7 (2001).
48. M. Dershwitz, Randel GI, Rosow CE, Fragen RJ, Connors PM, Librojo ES, Shaw DL, Peng AW, Jamerson BD, Initial clinical experience with remifentanil, a new opioid metabolized by esterases, Anesth Analg, 81: 619-23 (1995).
49. C.W. Hogue, Jr., Bowdle TA, O'Leary C, Duncalf D, Miguel R, Pitts M, Streisand J, Kirvassilis G, Jamerson B, McNeal S, Batenhorst R, A multicenter evaluation of total intravenous anesthesia with remifentanil and propofol for elective inpatient surgery, Anesth Analg, 83: 279-85 (1996).
50. J. Vuyk, Mertens MJ, Olofsen E, Burm AGL, Bovill JG, Propofol anesthesia and rational opioid selection. Anesthesiology 87: 1549-1562 (1997).
51. T.A. Bowdle, Camporesi EM, Maysick L, Hogue CW, Miguel RV, Pitts M, Streisand JB, A multicenter evaluation of remifentanil for early postoperative analgesia, Anesth Analg 83: 1292-97 (1996).
52. R.J. Fragen, Fitzgerald PC, Is an infusion pump necessary to safely administer remifentanil? Anesth Analg 90: 713-6 (2000).
53. D. Fourel, Almanza L, Aubouin JP, Guiavarch M, Remifentanil, postoperative respiratory depression after purging of the infusion line, Ann Fr Anesth Reanim 18: 358-9 (1999).
54. J. Schuttler, Albrecht S, Breivik H, Osnes S, Prys-Roberts C, Holder K, Chauvin M, Viby-Mogensen J, Mogensen T, Gustafson I, Lof L, Noronha D, Kirkham AJ, A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery, Anaesthesia 52: 307-17 (1997).
55. G.P. Joshi Jamerson BD, Roizen MF, Fleisher L, Twersky RS, Warner DS, Colopy M, Is there a learning curve associated with the use of remifentanil? Anesth Analg 91: 1049-55 (2000).
56. S.E. Milne SE, Kenny GN, Future applications for TCI systems, Anaesthesia 53 Suppl 1: 56-60 (1998).
57. P. Olivier, Sirieix D, Dassier P, D'Attellis N, Baron JF, Continuous infusion of remifentanil and target-controlled infusion of propofol for patients undergoing cardiac surgery: a new approach for scheduled early extubation, J Cardiothorac Vasc Anesth, 14: 29-35 (2000).
58. S. Schraag, Kenny GN, Mohl U, Georgieff M, Patient-maintained remifentanil target-controlled infusion for the transition to early postoperative analgesia, Br J Anaesth, 81: 365-8 (1998).
59. S.E. Milne, Horgan PG, Kenny GN, Target-controlled infusions of propofol and remifentanil with closed-loop anaesthesia for hepatic resection, Anaesthesia 57: 93 (2002).
60. M.M. Struys, De Smet T, Versichelen LF, Van De Velde S, Van den Broecke R, Mortier EP, Comparison of closed-loop controlled administration of propofol using Bispectral Index as the controlled variable versus "standard practice" controlled administration, Anesthesiology 95: 6-17 (2001).
61. M. Lauwers, Camu F, Breivik H, Hagelberg A, Rosen M, Sneyd R, Horn A, Noronha D, Shaikh S, The safety and effectiveness of remifentanil as an adjunct sedative for regional anesthesia, Anesth Analg 88: 134-40, (1999).
62. M.L. Mingus, Monk TG, Gold MI, Jenkins W, Roland C, Remifentanil versus propofol as adjuncts to regional anesthesia. Remifentanil 3010 Study Group, J Clin Anesth 10: 46-53 (1998).
63. F.S. Servin, Raeder JC, Merle JC, Wattwil M, Hanson AL, Lauwers MH, Aitkenhead A, Many J, Reite K, Martisson S, Wostyn L, Remifentanil sedation compared with propofol during regional anaesthesia, Acta Anaesthesiol Scand, 46: 309-15 (2002).
64. A. Holas, Krafft P, Marcovic M, Quehenberger F, Remifentanil, propofol or both for conscious sedation during eye surgery under regional anaesthesia, Eur J Anaesthesiol 16: 741-8 (1999).
65. E. Sundman, Witt H, Sandin R, Kuylenstierna R, Boden K, Ekberg O, Eriksson LI, Pharyngeal function and airway protection during subhypnotic concentrations of propofol, isoflurane, and sevoflurane: volunteers examined by pharyngeal videoradiography and simultaneous manometry, Anesthesiology 95: 1125-32 (2001).
66. B. Ouignard, Menigaux C, Dupont X, Fletcher D, Chauvin M, The effect of remifentanil on the blspectral index change and hemodynamic responses after orotracheal intubation, Anesth Analg 90: 161-7 (2000).
67. I.A. McNeil, Culbert B, Russell I, Comparison of intubating conditions following propofol and succinytcholine with propofol and remifentanil 2 micrograms kg-1 or 4 micrograms kg-1, Br J Anaesth 85: 623-5 (2000).
68. A.S. Habib, Parker JL, Maguire AM, Rowbotham DJ, Thompson JP, Effects of remifentanil and alfentanil on the cardiovascular responses to induction of anaesthesia and tracheal intubation in the elderly, Br J Anaesth 88: 430-3 (2002).
69. A.M. Maguire AM, Kumar N, Parker JL, Rowbotham DJ, Thompson JP, Comparison of effects of remifentanit and atfentanil on cardiovascular response to tracheal intubation in hypertensive patients, Br J Anaesth 86: 90-3 (2001).
70. U.M. Klemola, Mennander S, Saarnivaara L, Tracheal intubation without the use of muscle relaxants: remifentanil or atfentanil in combination with propofol, Acta Anaesthesiol Scand 44: 465-9 (2000).
71. M.P. Lee, Kua JS, Chiu WK, The use of remifentanil to facilitate the insertion of the laryngeal mask airway, Anesth Analg 93: 359-62 (2001).
72. K. Grewal, Samsoon G, Facilitation of laryngeal mask airway insertion: effects of remifentanit administered before induction with target-controlled propofol infusion, Anaesthesia 56: 897-901 (2001).
73. J. Guy, Hindman BJ, Baker KZ, Borel CO, Maktabi M, Ostapkovich N, Kirchner J, Todd MM, Fogarty-Mack P, Yancy V, Sokoll MD, McAllister A, Roland C, Young WL, Warner DS, Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions, Anesthesiology 86: 514-24 (1997).
74. M.B. Howie, Cheng D, Newman MF, Pierce ET, Hogue C, Hillel Z, Bowdle TA, Bukenya D, A randomized double-blinded multicenter comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery, Anesth Analg 92: 1084-93 (2001).
75. D.P. Cartwright, Kvalsvik O, Cassuto J, Jansen JP, Wall C, Remy B, Knape JT, Noronha D, Upadhyaya BK, A randomized, blind comparison of remifentanil and alfentanil during anesthesia for outpatient surgery, Anesth Analg 85: 1014-9 (1997).
76. J.R. Sneyd, Camu F, Doenicke A, Mann C, Holgersen O, Helmers JH, Appelgren L, Noronha D, Upadhyaya BK, Remifentanil and fentanyl during anaesthesia for major abdominal and gynaecological surgery. An open, comparative study of safety and efficacy, Eur J Anaesthesiol 18: 605-14 (2001).
77. R.R. McGregor, Allan LG, Sharpe RM, Thornton C, Newton DE, Effect of remifentanil on the auditory evoked response and haemodynamic changes after intubation and surgical incision, Br J Anaesth 81: 785-6 (1998).
78. M. Gemma, Tommasino C, Cozzi S, Narcisi S, Mortini P, Losa M, Soldarini A, Remifentanil provides hemodynamic stability and faster awakening time in transsphenoidal surgery, Anesth Analg 94: 163-8 (2002).
79. P.W. Doyle, Coles JP, Leary TM, Brazier P, Gupta AK, A comparison of remifentanil and fentanyl in patients undergoing carotid endarterectomy, Eur J Anaesthesiol, 18: 13-9 (2001).
80. A. Casati, Albertin A, Fanelli G, Deni F, Berti M, Danelli G, Grifoni F, Tom G, A comparison of remifentanil and sufentanil as adjuvants during sevoflurane anesthesia with epidural analgesia for upper abdominal surgery: effects on postoperative recovery and respiratory function, Anesth Analg 91: 1269-73 (2000).
81. G. Balakrishnan, Raudzens P, Samra SK, Song K, Boening JA, Bosek V, Jamerson BD, Warner DS, A comparison of remifentanil and fentanyl in patients undergoing surgery for intracranial mass lesions, Anesth Analg 91: 163-9 (2000).
82. A.Y. Bekker, Berklayd P, Osborn I, Bloom M, Yarmush J, Turndorf H, The recovery of cognitive function after remifentanil-nitrous oxide anesthesia is faster than after an isoflurane-nitrous oxide-fentanyl combination in elderly patients, Anesth Analg 1: 117-22 (000).
83. J. Ohanen, Olkkola KT, Verkkala K, Heikkinen L, Jarvinen A, Salmenpera M, A comparison of remifentanil and alfentanil for use with propofol in patients undergoing minimally invasive coronary artery bypass surgery, Anesth Analg 90: 1269-74 (000).
84. G. Natalini, Fassini P, Seramondi V, Amicucci G, Toninelli C, Cavaliere S, Candiani A, Remifentanil vs. fentanyl during interventional rigid bronchoscopy under general anaesthesia and spontaneous assisted ventilation, Eur J Anaesthesiol 16: 605-9 (1999).
85. L.H. Wee, Moriarty A, Cranston A, Bagshaw O, Remifentanil infusion for major abdominal surgery in small infants, Paediatr Anaesth 9: 415-8 (1999).
86. R.S. Twersky, Jamerson B, Warner DS, Fleisher LA, Hogue S, Hemodynamics and emergence profile of remifentanil versus fentanyl prospectively compared in a large population of surgical patients, J Clin Anesth 13: 407-16 (2001).
87. L.A. Fleisher, Hogue S, Colopy M, Twersky RS, Warner DS, Jamerson BD, Tuman KJ, Glass PS, Roizen MF, Does functional ability in the postoperative period differ between remifentanil- and fentanyl-based anesthesia? J Clin Anesth 13: 401-6 (2001).
88. W. Wilhelm, Schlaich N, Harrer J, Kleinschmidt S, Muller M, Larsen R, Recovery and neurological examination after remifentanil-desflurane or fentanyl-desflurane anaesthesia for carotid artery surgery. Br J Anaesth 86: 44-9 (001).
89. P.J. Davis, Finkel JC, Orr RJ, Fazi L, Mulroy JJ, Woelfel SK, Hannallah RS, Lynn AM, Kurth CD, Moro M, Henson LG, Goodman DK, Decker MD, A randomized, double-blinded study of remifentanil versus fentanyl for tonsillectomy and adenoidectomy surgery in pediatric ambulatory surgical patients, Anesth Analg 90: 863-71 (2000).
90. D. Fletcher, Pinaud M, Scherpereel P, Clyti N, Chauvin M, The efficacy of intravenous 0.15 versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery, Anesth Analg 90: 666-71 (2000).
91. B.M. Cox, Ginsburg M, Osman OH: Acute tolerance to narcotic analgesic drugs in rats, British Journal of Pharmacology 33: 245-56 (1968).
92. H.R. Vinik, Kissin I: Rapid development of tolerance to analgesia during remifentanil infusion in humans, Anesth Analg 86: 1307-11 (1998).
93. B. Guignard, Bossard AE, Coste C, Sessler DI, Lebrault C, Alfonsi P, Fletcher D, Chauvin M, Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement, Anesthesiology 93: 409-17 (2000).
94. Y.Y. Chia, Liu K, Wang JJ, Kuo MC, Ho ST, Intraoperative high dose fentanyl induces postoperative fentanyl tolerance, Can J Anaesth 46: 872-7 (1999).
95. I. Kissin, Lee SS, Arthur GR, Bradley EL, Jr., Time course characteristics of acute tolerance development to continuously infused alfentanil in rats, Anesth Analg 83: 600-5 (1996).
96. J.W. Mandema, Wada DR, Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat, J Pharmacol Exp Ther 275: 1185-94 (1995).
97. L.I. Cortinez, Brandes V, Munoz HR, Guerrero ME, Mur M, No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia, Br J Anaesth 87: 866-9 (2001).
98. S. Schraag, Checketts MR, Kenny GN, Lack of rapid development of opioid tolerance during alfentanil and remifentanil infusions for postoperative pain, Anesth Analg 89: 753-7 (1999).
99. V. Jevtovic-Todorovic, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW, Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin, Nat Med 4: 460-3 (1998).
100. I. Kissin, Bright CA, Bradley EL, Jr., The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg; 91, 1483-8 (2000).
101. E.S. Fu, Miguel R, Scharf JE, Preemptive ketamine decreases postoperative narcotic requirements in patients undergoing abdominal surgery, Anesth Analg 84: 1086-90 (1997).
102. W. Jaksch, Lang S, Reichhalter R, Raab G, Dann K, Fitzal S, Perioperative small-dose S(+)-ketamine has no incremental beneficial effects on postoperative pain when standard-practice opioid infusions are used, Anesth Analg 94: 981-6 (2002).
103. P.E. Pendeville, Kabongo F, Veyckemans F: Use of remifentanil in combination with desflurane or propofol for ambulatory oral surgery, Acta Anaesthesiol Belg 52: 181-6 (2001).
104. E. Calderon, Pernia A, De Antonio P, Calderon-Pla E, Torres LM. A comparison of two constant-dose continuous infusions of remifentanil for severe postoperative pain, Anesth Analg 92: 715-9 (2001).
105. E. Kochs, Cote D, Deruyck L, Rauhala V, Puig M, Polati E, Verbist J, Upadhyaya B, Haigh C, Postoperative pain management and recovery after remifentanil-based anaesthesia with isoflurane or propofol for major abdominal surgery, Br J Anaesth 84: 169-73 (2000).
106. H.S. Minkowitz, Postoperative pain management in patients undergoing major surgery after remifentanil vs. fentanyl anesthesia, Can J Anaesth 47: 522-8 (2000).
107. D.C.H. Cheng, Karski J, Peniston C, Raveendran G, Asokumar B, Carroll J, David T, Sandler A, Early tracheal extubation after coronary artery bypass graft srugery reduces costs and improves resource use, Anesthesiology 85: 1300-1310 (1996).
108. L.G. Michelsen LG, Holford NH, Lu W, Hoke JF, Hug CC, Bailey JM, The pharmacokinetics of remifentanil in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass, Anesth Analg 93: 1100-5 (2001).
109. A. Lehmann, Zeitler C, Thaler E, Isgro F, Boldt J, Comparison of two different anesthesia regimens in patients undergoing aortocoronary bypass grafting surgery: sufentanil-midazolam versus remifentanilpropofol, J Cardiothorac Vasc Anesth 14: 416-20 (2000).
110. P. Latham, Zarate E, White PF, Bossard R, Shi C, Morse LS, Douning LK, Chi L, Fast-track cardiac anesthesia: a comparison of remifentanil plus intrathecal morphine with sufentanil in a desflurane-based anesthetic, J Cardiothorac Vasc Anesth 14: 645-51 (2000).
111. T. Möllhoff T, Herregods L, Moerman A, Blake D, MacAdams C, Demeyere R, Kirnö K, Dybvik T, Shaikh S, Group TRS, Comparative efficacy and safety of remifentanil and fentanyl in "fast track" coronary artery bypass graft surgery: a randomized, double-blind study, Br J Anaesth 87: 718-26 (2001).
112. J.Y. Wang JY, Winship SM, Thomas SD, Gin T, Russell GN, Induction of anaesthesia in patients with coronary artery disease: a comparison between sevoflurane-remifentanil and fentanyl-etomidate, Anaesth Intensive Care 27: 363-8 (1999).
113. S. Kazmaier S, Hanekop GG, Buhre W, Weyland A, Busch T, Radke OC, Zoelffel R, Sonntag H, Myocardial consequences of remifentanil in patients with coronary artery disease, Br J Anaesth 84: 578-83 (2000).
114. G.N. Djaiani GN, Ali M, Heinrich L, Bruce J, Carroll J, Karski J, Cusimano RJ, Cheng DC, Ultra-fast-track anesthetic technique facilitates operating room extubation in patients undergoing off-pump coronary revascularization surgery, J Cardiothorac Vasc Anesth 15: 152-7 (2001).
115. E. Zarate, Latham P, White PF, Bossard R, Morse L, Douning LK, Shi C, Chi L, Fast-track cardiac anesthesia: use of remifentanil combined with intrathecal morphine as an alternative to sufentanil during desflurane anesthesia, Anesth Analg 91: 283-7 (2000).
116. M. Engoren, Luther G, Fenn-Buderer N, A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anesthesia, Anesth Analg 93: 859-64 (2001).
117. D.C. Cheng, Newman MF, Duke P, Wong DT, Finegan B, Howie M, Fitch J, Bowdle TA, Hogue C, Hillel Z, Pierce E, Bukenya D, The efficacy and resource utilization of remifentanil and fentanyl in fast-track coronary artery bypass graft surgery: a prospective randomized, double-blinded controlled, multi-center trial, Anesth Analg 92: 1094-102 (2001).
118. J.R. Sneyd, Whaley A, Dimpel HL, Andrews CJ, An open, randomized comparison of alfentanil, remifentanil and alfentanil followed by remifentanil in anaesthesia for craniotomy, Br J Anaesth 81: 361-4 (1998).
119. J.P. Coles, Leary TS, Monteiro JN, Brazier P, Summors A, Doyle P, Matta BF, Gupta AK, Propofol anesthesia for craniotomy: a double-blind comparison of remifentanil, alfentanil, and fentanyl, J Neurosurg Anesthesiol 12: 15-20 (2000).
120. H. Berkenstadt H, Perel A, Hadani M, Unofrievich I, Ram Z, Monitored anesthesia care using remifentanil and propofol for awake craniotomy, J Neurosurg Anesthesiol 13: 246-9 (2001).
121. K.B. Johnson KB, Egan TD, Remifentanil and propofol combination for awake craniotomy: case report with pharmacokinetic simulations, J Neurosurg Anesthesiol 10: 25-9 (1998).
122. T. Tijero, Ingelmo I, Garcia-Trapero J, Puig A: Usefulness of Monitoring Brain Tissue Oxygen Pressure During Awake Craniotomy for Tumor Resection: A Case Report, J Neurosurg Anesthesiol 14: 149-152 (2002).
123. A.M. Debailleul, Bortlein ML, Touzet G, Krivosic-Horber R, Particularités anesthésiques de la neurochirurgie stéréotaxique, Ann Fr Anesth Reanim 21: 170-8 (2002).
124. I.A. Herrick IA, Craen RA, Blume WT, Novick T, Gelb AW, Sedative doses of remifentanil have minimal effect on ECoG spike activity during awake epilepsy surgery, J Neurosurg Anesthesiol 14: 55-8 (2002).
125. C.T. Wass, Grady RE, Fessler AJ, Cascino GD, Lozada L, Bechtle PS, Marsh WR, Sharbrough FW, Schroeder DR, The effects of rernifentanil on epileptiform discharges during intraoperative electrocorticography in patients undergoing epilepsy surgery, Epilepsia 42: 1340-4 (2001).
126. H. Berkenstadt, Perel A, Ram Z, Feldman Z, Nahtomi-Shick O, Hadani M, Anesthesia for magnetic resonance guided neurosurgery: initial experience with a new open magnetic resonance imaging system. J Neurosurg Anesthesiol 13: 158-62 (2001).
127. R. Jones, Pegrum A, Stacey RG, Patient-controlled analgesia using remifentanil in the parturient with thrombocytopaenia. Anaesthesia 54: 461-5 (1999).
128. F. Roelants, De Franceschi E, Veyckemans F, Lavand'homme P, Patient-controlled intravenous analgesia using remifentanil in the parturient, Can J Anaesth 48: 175-8 (2001).
129. J.A. Thurlow, Waterhouse P, Patient-controlled analgesia in labour using remifentanil in two parturients with platelet abnormalities, Br J Anaesth 84: 411-3 (2000).
130. M.D. Owen, Poss MJ, Dean LS, Harper MA, Prolonged intravenous remifentanil infusion for labor analgesia, Anesth Analg 94: 918-9 (2002).
131. A.J. Olufolabi, Booth JV, Wakeling HG, Glass PS, Penning DH, Reynolds JD, A preliminary investigation of remifentanil as a labor analgesic. Anesth Analg 91: 606-8 (2000).
132. T.A. Saunders, Glass PS, A trial of labor for remifentanil. Anesth Analg 94: 771-3 (2002).
133. J.M. Blair, Hill DA, Fee JP, Patient-controlled analgesia for labour using remifentanil: a feasibility study. Br J Anaesth 87: 415-20 (2001).
134. J.A. Thurlow, Laxton CH, Dick A, Waterhouse P, Sherman L, Goodman NW, Remifentanil by patient-controlled analgesia compared with intramuscular meperidine for pain relief in labour, Br J Anaesth 88: 374-8 (2002).
135. P.O. Maitre, Vozeh S, Heykants J, Thomson JA, Stanski DR, Population pharmacokinetics of alfentanil: average dose-plasma concentraiton relationship and interindividual variability, Anesthesiology 66: 3-12 (1987).